Daiichi Sankyo Daiichi Sankyo Thailand’s managing director explains the Thai subsidiary’s success under his leadership, Thailand’s untapped potential as a regional economic center in Southeast Asia and his company’s role in providing high quality products for consumers in Thailand. What have been your greatest challenges and achievements as Managing Director? During my tenure in…
Daiichi Sankyo Austria Can you give our readers a brief overview of Daiichi Sankyo in Austria as well as its market positioning and growth factors in 2012? Daiichi Sankyo Austria GmbH is the Austrian affiliate of Daiichi Sankyo, a global pharmaceutical company that focuses on researching and marketing innovative medications. The company’s roots…
DAIICHI SANKYO TURKEY Would you like to come back for our readers on the main milestones in Daiichi Sankyo’s development over the past few years in Turkey and how it positions itself in this market? Daiichi Sankyo entered the Turkish market four years ago. At the time, little did we know that we…
Daiichi Sankyo Germany DAIICHI SANKYO in Germany, Austria and Switzerland DAIICHI SANKYO wants to be a Global Pharma Innovator with Germany at the center of this process on the European continent. An example of this development is your manufacturing facility in Pfaffenhofen, a basis to export to more than 50 countries. Can you…
Daiichi Sankyo Nederland “Two traditions one vision” was the phrase used to describe the 2005 merger that formed Daiichi Sankyo as it is today. While referring specifically to a corporate merger, its message of marrying two different cultures can be applied to the process of managing the Benelux region given the different market…
Gedeon Richter Czech Republic Mr. Gyürüsi, Gedeon Richter is a 111-year-old company that is synonymous with the Central and Eastern European pharma industry. The business has been present in Czechoslovakia since 1956, and has acted independently in the Czech Republic since 1992. Can you give our readers a more detailed idea of the history…
China MSD China’s Michel Vounastos gives his initial impressions of the opportunities and challenges inherent in the Chinese healthcare market, and highlights how MSD’s offerings are able to address specific gaps in the country. You just arrived in China in February. The country managers we’ve met have all been here for…
Laboratorios Richmond What have been the recent major milestones for Richmond? One of the milestones for Laboratorios Richmond was to have developed the first branded oncological generic in the world. For Laboratorios Richmond to be developing combinations of different molecules from different originator laboratories is very important as well, as it provides…
Gedeon Richter Gedeon Richter’s Erik Bogsch discusses the company’s 100th anniversary, it’s growing international footprint and the future of Hungarian pharma. Gedeon Richter is known to be the flagship pharmaceutical company in Hungary, and can proudly celebrate its 110th birthday this year. How would you describe Gedeon Richter to our readers?…
Gedeon Richter Since establishing Gedeon Richter’s operations here 16 years ago, you’ve been involved in the full array of the pharmaceutical spectrum, from R&D, sourcing API, sales and marketing of finished products, and joint ventures with local companies. To begin, would you introduce the company’s China operations to our readers? First off,…
Medichem (Malta) Medichem began production at its plant in Malta in 2006. Can you give us a brief overview of the facilities, and of the importance of the subsidiary to Corporación Medichem as a group? Medichem was set up as a state-of-the-art facility for the manufacture of active pharmaceutical ingredients (APIs) in…
Daiichi Sankyo France When we met your Italian colleague, he noted that they had tripled their turnover in a five year period. You haven’t done badly yourself in the relatively short period of time you’ve been present in the Market. Is this a European-wide phenomenon for Daiichi Sankyo or is there something special…
See our Cookie Privacy Policy Here
